FDA inspection
Lupin Limited (Unit II): FDA inspection ending Aug 11, 2023
FDA inspection 1218049 · No Action Indicated (NAI) · Mandideep
Key facts
| Inspection ID | 1218049 |
|---|---|
| Firm | Lupin Limited (Unit II) |
| FEI number | 3007756473 |
| Address | 198 - 202 New Industrial Area No 2 |
| City | Mandideep |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Aug 11, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data